Mansalinog, Emilyn B.
HRN: 22-26-8401 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/05/2023
CEFUROXIME 1.5GM (VIAL)
01/05/2023
01/11/2023
IV
1.5
Q8H
AGE W/ Mild DHN
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes